Results 201 to 210 of about 268,538 (298)

Clinical Outcomes of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in COVID-19 Patients With Pre-existing Cardiac Comorbidities: A Literature Review. [PDF]

Cureus, 2023
Srinivasa S, Kaur S, Dharani A, Choi E, Kalidas A, Slater R, Mifflin S.   +6 more
europepmc   +1 more source

Angiotensin converting enzyme inhibitors in the elderly. [PDF]

BMJ, 1987
J P Milnes, A J Shaw
openaire   +3 more sources

Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. [PDF]

Cochrane Database Syst Rev
Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF.   +4 more
europepmc   +1 more source

Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study. [PDF]

Medicine (Baltimore), 2023
Hu WS, Lin CL.
europepmc   +1 more source

The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors. [PDF]

Iran J Med Sci
Abd-El-Fatah SS, Fathy MA, Alabiad MA, Aljafil R, Gobran MA, Ahmad EA, Alsharidah AS, Alorini M, Alnasser SM, Awadh SA, Morgan EN.   +10 more
europepmc   +1 more source

Antihypertensive Action of a New Angiotensin Converting Enzyme Inhibitor, (R)-3-[(S)-1-Carboxy-5-(4-Piperidyl)pentyl]amino-4-Oxo-2,3,4,5-Tetrahydro-1,5-Benzothiazepine-5-Acetic Acid (CV-5975), in Various Hypertensive Models

, 1988
Yoshiyuki Inada, Masao J. Tanabe, K Kawazoe, Kohei Nishikawa   +3 more
openalex   +1 more source

Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET). [PDF]

Am J Epidemiol
Baptiste PJ, Wong AYS, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, Mann JFE, Cunnington M, Teo K, Bangdiwala SI, Gao P, Tomlinson L, Wing K.   +13 more
europepmc   +1 more source

Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).

, 1981
Masanobu Honda, Yoichi Izumi, Yukinori Kawahara, Michinobu Hatano   +3 more
openalex   +2 more sources

Efficacy of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]

Cardiol Res
Llerena-Velastegui J, Santamaria-Lasso M, Mejia-Mora M, Santander-Aldean M, Granda-Munoz A, Hurtado-Alzate C, de Jesus ACFS, Baldelomar-Ortiz J.   +7 more
europepmc   +1 more source

Studies on angiotensin converting enzyme inhibitors. III. 2-Carboxyethylcarbamoyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives.

, 1985
Kimiaki Hayashi, K. NUNAMI, Kazuo Sakai, Yasuhiko Ozaki, Jyoji Kato, KEIZO KINASHI, N. YONEDA   +6 more
openalex   +2 more sources